Development of a Screen-Printable Liquid Metal Ink on PDMS Substrates Toward Flexible Conductive Electronics
Abstract
In this study, poly(vinylpyrrolidone) (PVP)-modified liquid metal (LM) particles were formulated into a mixed-solvent system comprising ethanol (EtOH), 1,2-propanediol (1,2-PG), and a trace amount of N,N-dimethylformamide (DMF). This design addresses the instability, poor wetting/adhesion on polydimethylsiloxane (PDMS), and limited rheological tunability of conventional LM inks for screen printing. By regulating solvent evaporation during drying, the system enables coordinated control over wettability, viscosity, shear-thinning behavior, and drying-induced film formation. At an LM:PVP weight ratio of 20:1, the contact angle on PDMS decreased from 115° to 17.8°. The ink exhibited pronounced shear-thinning characteristics with tunable viscosity in the range of 1000-3000 cP, meeting the screen-printing requirements of facile mesh passage and rapid setting. Following laser activation, the printed conductive patterns demonstrated stable electrical performance, with a resistance drift of less than 1% after 14 days of storage and a ΔR/R0 of less than 1% after 3000 bending cycles at a bending diameter of 1 cm. Furthermore, a resistance drift of less than 3% was observed after 1000 stretching cycles at 30% strain. This study proposes a viable materials and processing strategy for the reliable screen printing of LM:PVP ink on PDMS substrates toward flexible conductive electronics. The motion-monitoring test is presented only as a preliminary proof-of-concept demonstration of…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.